JAMA Network
What The Study Did: Researchers assessed the occurrence of short-term adverse events in adults age 60 or older in Israel who received a booster dose of the Pfizer-BioNTech COVID-19 vaccine.
Authors: Shay Ben-Shachar, M.D., of Clalit Health Services in Tel Aviv, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.7657)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
